http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-329556-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 1998-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7633fb30cad12ad050d24cff143c07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_effa40479d27c0731117d66d556f5e26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc4e519aa644d65e9e4b3bf08259eb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fb314f8a4e89284490092e4d31d7bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e36296972c51ffab5f7c34fe8ce82637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7780ff5da4e5a8395976147ff35a3ee9
publicationDate 2000-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-329556-A
titleOfInvention Use of a composition containing ramipril in instant release form and a dihydroxypyridine compound in sustained release form in treating hypertension
abstract This synergistic composition in solid fixed dosage form, for treating hypertension, comprises: 1. Rampricial in instant release form; and 2. A dihydropyridine in extended dosage form selected from felodipine, nitrendipine, nifedipine, or lacidipine.
priorityDate 1994-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485

Total number of triples: 43.